HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Miosis during vitreoretinal surgery.

Abstract
Maintenance of wide pupillary dilation during vitreoretinal surgery can be important in successful completion of the operation. This study identified factors associated with intraoperative miosis. Also, flurbiprofen, a topically applied nonsteroidal anti-inflammatory agent, was evaluated for its efficacy in preventing intraoperative miosis in a prospective, randomized study of 99 consecutive patients. Factors associated with intraoperative miosis included duration of surgery greater than 90 minutes, preoperative afferent pupillary defect, and recent previous surgery. Preoperative treatment with flurbiprofen did not decrease the risk of intraoperative miosis.
AuthorsW E Smiddy, B M Glaser, R G Michels, S Vitale
JournalRetina (Philadelphia, Pa.) (Retina) Vol. 10 Issue 1 Pg. 42-6 ( 1990) ISSN: 0275-004X [Print] United States
PMID2188314 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Flurbiprofen
Topics
  • Chi-Square Distribution
  • Flurbiprofen (therapeutic use)
  • Humans
  • Intraoperative Complications (prevention & control)
  • Miosis (prevention & control)
  • Preoperative Care
  • Prognosis
  • Random Allocation
  • Randomized Controlled Trials as Topic
  • Retina (surgery)
  • Risk Factors
  • Vitreous Body (surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: